• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Nephros to Participate in the Benchmark Company Annual Discovery One-on-One Investor Conference on December 11, 2024 in NYC

    12/4/24 9:00:00 AM ET
    $NEPH
    Medical/Dental Instruments
    Health Care
    Get the next $NEPH alert in real time by email

    SOUTH ORANGE, N.J., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will be participating in the Benchmark Company 13th Annual Discovery One-on-One Investor Conference. The event is scheduled for Wednesday, December 11, 2024, at the New York Athletic Club in New York City.

    Robert Banks, CEO and Judy Krandel, CFO of Nephros, Inc. will be hosting one-on-one and group investor meetings. If you would like to schedule a 1x1 investor meeting please make sure you are registered here:

    The conference offers emerging growth and dynamic publicly traded companies access to institutional and individual investors in a unique one-on-one format during which Nephros will be participating in one-on-one meetings with investors and analysts throughout the day.

    About The Benchmark Company

    The Benchmark Company is an institutionally focused, research driven, sales trading and investment banking firm. We were founded in 1988 and are headquartered in New York City.  Our focus is on fostering the long-term success of our corporate clients through raising capital, providing strategic advisory services, generating insightful research, and developing institutional sponsorship by leveraging the firm's sales, trading, and equity research capabilities.  https://www.benchmarkcompany.com.

    About Nephros

    Nephros is committed to improving the human relationship with water through leading, accessible technology. We provide innovative water filtration products and services, along with water-quality education, as part of an integrated approach to water safety. Nephros goods serve the needs of customers within the healthcare and commercial markets, offering both proactive and emergency solutions for water management.

    For more information about Nephros, please visit us at nephros.com.

    Investor Relations Contacts:

    Kirin Smith, President

    PCG Advisory, Inc.

    (646) 823-8656

    [email protected]

    Robert Banks, CEO

    Nephros, Inc.

    (201) 343-5202 x110

    [email protected]



    Primary Logo

    Get the next $NEPH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Q&A

    New
    • What event is Nephros, Inc. participating in?

      Nephros, Inc. will be participating in the Benchmark Company 13th Annual Discovery One-on-One Investor Conference.

    • When and where is the Benchmark Company 13th Annual Discovery One-on-One Investor Conference taking place?

      The conference is scheduled for Wednesday, December 11, 2024, at the New York Athletic Club in New York City.

    • Who from Nephros, Inc. will be attending the conference?

      Robert Banks (CEO) and Judy Krandel (CFO) will be hosting the investor meetings.

    • What is the purpose of the Benchmark Company Discovery Conference?

      The conference allows publicly traded companies to meet and engage with institutional and individual investors in a one-on-one meeting format.

    • What is Nephros, Inc.'s primary focus and commitment?

      Nephros is committed to improving the relationship with water through innovative water filtration products and services.

    Recent Analyst Ratings for
    $NEPH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $NEPH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • B. Riley FBR initiated coverage on Nephros with a new price target

      B. Riley FBR initiated coverage of Nephros with a rating of Buy and set a new price target of $12.50

      1/26/21 6:12:57 AM ET
      $NEPH
      Medical/Dental Instruments
      Health Care